netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Chapter Links...
 Details...
04.09.03  Expand sub section  Drugs used in essential tremor, chorea, tics, and related disorders
Botulinum Toxin Type A  (Botox®/ Xeomin® )
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine

Supported in line with CCG Commissioning policy. Please ensure correct brand is prescribed as per CCG policy. 
Dysport® should be reserved for use in a) ophthalmology for use in extra ocular muscles b)patients already on therapy who had previously not responded to Botox®

NOT supported for chronic constipation in children

 
Link  Leicestershire Evaluation: Botulinum (Xeomin®)
Link  Leicestershire Guidance: Botulinum Toxin Commissioning Policy
   
Botulinum Toxin Type B ( Neurobloc® )
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
Neurology use only  
   
Riluzole (Rilutek®)
View adult BNF View SPC online  Track Changes
Formulary
Amber SCA
High Cost Medicine
 
Link  SCA: Riluzole (Rilutek®)in the treatment of Amylotrophic Lateral Sclerosis form of Motor Neurone Disease
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety. All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry   

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).  

Amber SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.   

Amber Simple

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.  

Green Conditional

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.   

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.   

netFormulary